Forma Therapeutics selects the R&D Logic platform for corporate planning, portfolio planning, tracking, time collection and reporting.
November 2015 — Located in Watertown, MA, Forma Therapeutics has selected the R&D Logic FP&A solution to manage their R&D intensive company. Forma is passionate about discovering and developing medicines that will make a difference in cancer and other genetically-driven diseases.
Viking Therapeutics selects the R&D Logic platform for corporate planning, portfolio planning, tracking, time collection and reporting.
October 2015 — Viking, located in San Diego, California has selected R&D Logic's software for planning, tracking, analysis and reporting. Viking Therapeutics is a clinical-stage biotherapeutics company focused on the development of novel, first-in-class or best-in-class therapies for metabolic and endocrine disorders.
Just Biotherapeutics selects the R&D Logic solution for corporate planning and reporting.
May 2015 — Just, located in Seattle, Washington has selected R&D Logic's software for planning, tracking, analysis and reporting. Just is an integrated design company focused on the technology of biotherapeutics, from molecule to manufacturing plant. Just believes that technological innovation will accelerate biotherapeutic development and dramatically reduce the cost of these vital medicines.
Retrophin selects the R&D Logic time collection solution.
January 2015 — Retrophin, located in New York, Cambridge and San Diego has selected R&D Logic's software for collecting and reporting R&D project effort and FTEs. Retrophin is a biopharmaceutical company focused on the discovery, acquisition, development and commercialization of drugs for the treatment of debilitating and often life-threatening diseases for which there are currently limited patient options.
Juno Therapeutics selects the R&D Logic solution for corporate planning and reporting.
September 2014 — Juno, located in Seattle, Washington has selected R&D Logic's software for planning, tracking, anlysis and reporting. Juno is a clinical-stage company that brings together three of the world's leading cancer centers - Fred Hutchinson Cancer Research Center, Memorial Sloan-Kettering Cancer Center and Seattle Children's Research Institute - in unique partnership to advance a broad pipeline of breakthrough immunotherapies.
Accelleron Pharma selects the R&D Logic solution for R&D project effort.
July 2014 — Acceleron, located in Cambridge, Massachusetts has selected R&D Logic's software for collecting and reporting project effort and FTEs. Acceleron aims to transform the lives of people suffering from cancer and orphan diseases by discovering and developing innovative therapies.
Mersana Therapeutics selects the R&D Logic time collection solution.
June 2014 — Mersana, located in Cambridge, Massachusetts has selected R&D Logic's software for collecting and reporting project effort and time off. Mersana engineers novel drug conjugates that maximize the potential of new and established therapeutic classes. Mersana technology harnesses the power and synergy of nanotechnology, biologics and small molecules has built a portfolio of innovative therapeutic antibodies, both in late-stage clinical development and in preclinical research.
Biomeasure, Inc. selects the R&D Logic software and services.
February 2014 — Ipsen Bioscience, a subsidiary of Ipsen, located in Milford, Massachusetts has selected R&D Logic software and services to manage their planning, tracking and reporting processes. Formerly Biomeasure, this research center in the Ipsen Group and is focused on discovering drugs in neuro-endocrinology.
XOMA Corporation selects the R&D Logic platform.
February 2014 — XOMA Corporation, located in Berkeley, California has selected R&D Logic platform to support global planning, tracking and reporting of the R&D porfolio and the overall corporation. XOMA has built a portfolio of innovative therapeutic antibodies, both in late-stage clinical development and in preclinical research.
Sutro Biopharma signs up to R&D Logic software and services.
January 2014 — Sutro Biopharma, located in South San Francisco, California has selected R&D Logic software and services to develop long term, mid-term and operational budgetes and to track, analyze and manage variances to actual results. In addition, Sutro employees and contractors will track their time effort to project using the RDLogic platform. Sutro Biopharma is developing a new generation of multi-functional antibody drug conjugate combination therapeutics and bifunctional antibody-based therapeutics for targeted cancer therapies.
Tetraphase Pharmaceuticals selects R&D Logic software.
December 2013 — Tetraphase Pharmaceuticals, located in Watertown, Massachusetts has selected R&D Logic software and services to automate FP&A processes: planning, tracking, analysis and reporting. Tetraphase is a clinical-stage biopharmaceutical company using its proprietary chemistry technology to create novel antibiotics for serious and life-threatening multi-drug resistant (MDR) infections.
Sarepta Therapeutics selects R&D Logic software.
December 2013 — Sarepta Therapeutics, located in Cambridge, Massachusetts has selected R&D Logic software and services to manage corporate planning, tracking, analysis and reporting. Sarepta Therapeutics is focused on developing first-in-class RNA-based therapeutics to improve and save the lives of people affected by serious and life-threatening rare and infectious diseases.
Enanta Pharmaceuticals selects R&D Logic platform software.
March 2013 — Enanta Pharmaceuticals, located in Watertown, Massachusetts has subscribed to R&D Logic software and services to manage corporate planning, tracking, reporting as well as time collection processes. Enanta is a research and development-focused biotechnology company that uses its robust chemistry-driven approach and drug discovery capabilities to create small molecule drugs in the infectious disease field.
BIND Biosciences selects R&D Logic's Time Collection software.
January 2013 — BIND Biosciences, located in Cambridge, Massachusetts has subscribed to R&D Logic software and services for collecting, managing and reporting collaborator project time, project FTEs as well as time off. BIND is a clinical-stage biopharmaceutical company developing a new class of highly selective targeted therapeutics called Accurins.
PNI Digital Media Inc. selects R&D Logic software and services.
October 2012 — PNIDigitalMedia, located in Vancouver, Canada has subscribed to R&D Logic software and services for managing planning, tracking, consolidation reporting as well as time collection. At its core, PNI Digital Media provides a proprietary transactional software platform that is used by leading retailers such as Costco, Walmart Canada, and CVS/pharmacy to sell millions of personalized products every year.
Solazyme selects R&D Time software and services.
October 2012 — Solazyme, located in South San Francisco, California has subscribed to R&D Logic software and services as the corporate-wide solution for collecting, managing and reporting project effort, FTEs as well as time off. Solazyme has pioneered an industrial biotechnology platform that harnesses the prolific oil-producing ability of microalgae.
Pfenex, Inc. selects R&D Logic software platform and services.
September 2012 — Pfenex, located in San Diego, California, has subscribed to R&D Logic software and services for managing planning, tracking, analysis and consolidation reporting. Pfenex is a leading biotechnology company focused on recombinant protein expression for a broad range of applications including therapeutic proteins, vaccines, research, reagents and biosimilars.
EnVivo Pharmaceuticals, Inc. subscribes to R&D Logic software and services.
August 2012 — EnVivo, located in Watertown, Massachusetts, has subscribed to R&D Logic software and services for managing FP&A corporate processes. EnVivo is developing its broad pipeline of diverse programs with a focus on leveraging novel mechanisms of action to treat CNS diseases like schizophrenia and Alzheimer’s disease in new ways and from multiple angles.
Epizyme, Inc. selects R&D Logic Plaform for the Business of Science.
June 2012 — Epizyme, located in Cambridge, Massachusetts, has subscribed to R&D Logic software and services for planning, tracking, time collection and consolidated reporting of the R&D Portfolio and of Corporate Financials. Epizyme is leading the discovery and development of small molecule histone methyltransferase(HMT)inhibitors, a new class of personalized therapeutics for the treatment of patients with genetically-defined cancers, based on breakthroughs in the field of epigenetics.
Aveo Pharmaceuticals, Inc. subscribes to R&D Logic Time Collection & Reporting software and services.
June 2012 — AVEO, located in Cambridge, Massachusetts, has subscribed to R&D Time software services to manage time collection, FTE and collaborations reporting. AVEO Oncology is a cancer therapeutics company committed to discovering, developing and commercializing targeted therapies to impact patients’ lives.